SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,590.81 |
Enterprise Value ($M) | 1,264.82 |
Book Value ($M) | 373.50 |
Book Value / Share | 5.09 |
Price / Book | 4.26 |
NCAV ($M) | 201.42 |
NCAV / Share | 2.75 |
Price / NCAV | 7.90 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.39 |
Return on Assets (ROA) | -0.26 |
Return on Equity (ROE) | -0.37 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.45 |
Current Ratio | 3.45 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 570.94 |
Assets | 743.03 |
Liabilities | 369.53 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 207.54 |
Operating Income | -209.30 |
Net Income | -187.12 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -157.37 |
Cash from Investing | 148.84 |
Cash from Financing | 10.12 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Rubric Capital Management LP | 7.85 | 35.67 | |
13G | Sumitomo Mitsui Trust Holdings, Inc. | 5.50 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
242,721 | 767,243 | 31.64 | |
161,674 | 535,413 | 30.20 | |
192,942 | 650,758 | 29.65 | |
249,185 | 811,337 | 30.71 | |
(click for more detail) |
Similar Companies | |
---|---|
RXRX – Recursion Pharmaceuticals, Inc. | SANA – Sana Biotechnology, Inc. |
SCPH – scPharmaceuticals Inc. | SLDB – Solid Biosciences Inc. |
SNDX – Syndax Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io